Monday’s Midday Movers: Acura Pharmaceuticals (ACUR), MannKind (MNKD), Microvision (MVIS), Fuelcell Energy (FCEL), ImmunoCellular Therapeutics (IMUC)

By Carrie Williams

So far Monday, March 6, NASDAQ is down -1.78% and the S&P is down -0.21%. Let’s take a look at this morning’s most active stocks and their recent analyst insights; Acura Pharmaceuticals (NASDAQ:ACUR), MannKind (NASDAQ:MNKD), Microvision (NASDAQ:MVIS), Fuelcell Energy (NASDAQ:FCEL) and ImmunoCellular Therapeutics (NYSE MKT:IMUC).

Acura Pharmaceuticals is up 17.35% in midday trading to $0.54. Shares opened today at $0.46. The company has a 52-week low of $0.46 and a 52-week high of $3.48. In the last 30 days, insiders have sold $1,067 worth of ACUR shares. Over the last 3 months, the insider sentiment on Acura Pharmaceuticals has been neutral based on 4 corporate insider transactions. This sentiment is lower than the average sector sentiment of insiders.

MannKind is down -12.87% in midday trading to $1.76. Shares opened today at $2.02. The company has a 52-week low of $1.74 and a 52-week high of $11.20. Over the last 3 months, the insider sentiment on MannKind has been positive based on 11 corporate insider transactions. This sentiment is higher than the average sector sentiment of insiders.

Microvision is down -10.81% in midday trading to $1.65. Shares opened today at $1.85. The company has a 52-week low of $0.89 and a 52-week high of $2.94. Over the last 3 months, the insider sentiment on Microvision has been positive based on 14 corporate insider transactions. This sentiment is slightly higher than the average sector sentiment of insiders.

Fuelcell Energy is down -10% in midday trading to $1.58. Shares opened today at $1.75. The company has a 52-week low of $1.25 and a 52-week high of $8.88. Over the last 3 months, the insider sentiment on Fuelcell Energy has been neutral based on 12 corporate insider transactions. This sentiment is higher than the average sector sentiment of insiders.

ImmunoCellular Therapeutics is down -9.82% in midday trading to $2.57. Shares opened today at $2.85. The company has a 52-week low of $1.83 and a 52-week high of $14.80. In the last 30 days, insiders have sold $6,732 worth of IMUC shares. Over the last 3 months, the insider sentiment on ImmunoCellular Therapeutics has been neutral based on 5 corporate insider transactions. This sentiment is lower than the average sector sentiment of insiders.